Sursa: Banca Naţională a României
View more
View less

Folow us

Modifică dimensiunea fontului:

The National COVID-19 Vaccination Coordination Committee (CNCAV) informs that, in the past 24 hours, 80,391 vaccine doses were administered, of which 64,001 - Pfizer, 8,056 - Moderna and 8,334 - AstraZeneca, according to data made available by the National Institute for Public Health through the National Electronic Vaccination Registry application.

According to a release sent by CNCAV to AGERPRES on Thursday, 51,141 persons were vaccinated with the first dose, and 29,250 with the second dose.

Since the start of the vaccination campaign, on December 27, 2020, 5,161,840 doses have been administered to 3,252,247 persons, of whom 1,342,654 have received just one dose and 1,909,593 received both doses.

In the past 24 hours, doctors noted 87 adverse reactions - 14 of the local type and 73 of the general type.

Furthermore, since the beginning of the vaccination campaign 14,037 adverse reactions to the vaccines made by Pfizer, Moderna and AstraZeneca were noted, 1,489 of the local type and 12,584 of the general type.

CNCAV mentions that 141 adverse reactions are under investigation.AGERPRES(RO - author: Roberto Stan, editor: Mihai Simionescu; EN - author: Razvan-Adrian Pandea, editor: Maria Voican)

The content of the website has the exclusive purpose of public informing.
All the information published on this website by AGERPRES is protected by relevant legal dispositions.
It is forbidden to copy, reproduce, recompile, decompile, distribute, publish, display, modify, create derived components or products or full services, as well as any exploitation of the site's content.
Details in the section Terms of Use. If you are interested in picking up AGERPRES news items, please contact the Marketing Department –

The use of the Comments section entails your obligation to respect the AGERPRES terms and conditions in regards to the publishing of comments on the

Sursa: Administrația Națională de Meteorologie


Dacă ai cont gratuit te loghezi cu adresa de email. Pentru a crea un cont gratuit accesează secțiunea “Crează cont”.

Dacă ai cont plătit te loghezi cu username. Pentru a vă crea un cont plătit vă rugăm să contactați:

Dacă nu puteți vizualiza această știre, contactați echipa AGERPRES pentru a vă abona la fluxurile de știri.